Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.
Adolescent
Adult
Betacoronavirus
/ genetics
COVID-19
COVID-19 Testing
COVID-19 Vaccines
Child
Clinical Laboratory Techniques
Conjunctivitis, Viral
/ diagnosis
Coronavirus Infections
/ diagnosis
Female
Humans
Male
Middle Aged
Nasal Cavity
/ virology
Pandemics
Pharynx
/ virology
Pneumonia, Viral
/ diagnosis
Prospective Studies
RNA, Viral
/ isolation & purification
Real-Time Polymerase Chain Reaction
SARS-CoV-2
Specimen Handling
Young Adult
Conjunctival swab
SARS-CoV-2
coronavirus disease-19
nasopharyngeal swab
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
6
6
2020
Statut:
ppublish
Résumé
To detect the presence of viral RNA of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in conjunctival swab specimens of coronavirus disease-19 (COVID-19) patients. Forty-five COVID-19 patients positive for real-time reverse transcription-polymerase chain reaction (RT-PCR) for SARS-CoV-2 in nasopharyngeal swab with or without ocular manifestations were included in the study. The conjunctival swab of each patient was collected by an ophthalmologist posted for COVID duty. Out of 45 patients, 35 (77.77%) were males and the rest were females. The mean age was 31.26 ± 12.81 years. None of the patients had any ocular manifestations. One (2.23%) out of 45 patients was positive for RT-PCR SARS-CoV-2 in the conjunctival swab. This study shows that SARS-CoV-2 can be detected in conjunctival swabs of confirmed cases of COVID-19 patients. Though the positivity rate of detecting SARS-CoV-2 in conjunctival swabs is very less, care should be exercised during the ocular examination of patients of COVID-19.
Identifiants
pubmed: 32461418
pii: IndianJOphthalmol_2020_68_6_1015_284769
doi: 10.4103/ijo.IJO_1287_20
pmc: PMC7508154
doi:
Substances chimiques
COVID-19 Vaccines
0
Covid-19 aAPC vaccine
0
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1015-1017Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603
pubmed: 24062443
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Med Virol. 2020 Jun;92(6):589-594
pubmed: 32100876
Ocul Surf. 2020 Jul;18(3):360-362
pubmed: 32289466
Lancet. 2020 Feb 22;395(10224):e39
pubmed: 32035510
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Med. 2011 Jan;17(1):105-9
pubmed: 21151139
J Pharm Anal. 2020 Apr;10(2):97-101
pubmed: 32292623
Br J Ophthalmol. 2004 Jul;88(7):861-3
pubmed: 15205225
J Infect Dis. 2014 Nov 15;210(10):1590-4
pubmed: 24837403